Botaneco's proprietary Hydresia and Hydresia(TM) G2 products are natural emulsifiers comprised of oleosomes, natural oil carrying structures derived from safflower seeds. Oleosomes are nature's warehouse, or storage facility, for the emollient oils, antioxidants and natural moisture barriers that serve to keep the skin soft, supple and young looking. Using a proprietary non-solvent aqueous extraction process, these oleosomes are isolated from the seed fully intact, and when used in skin care applications can provide lasting protection to the skin. Hydresia(TM) and Hydresia(TM) G2 are natural, renewable replacements for hydrocarbon derived petrolatum, mineral oil and non-ionic surfactants.
Botaneco is the global developer and marketer of innovative
oleosome-based ingredients to the personal care and OTC topical markets. As
a technologically driven provider of high performance, proprietary oleosome
based ingredients, Botaneco is committed to developing groundbreaking
ingredients that offer multifunctional, tangible and documented benefits to
both formulators and consumers. Botaneco's manufacturing facility is
located in Calgary, Canada while its sales and marketing and research and
development laboratories are in Bensalem PA.
More information is available and can be accessed at http://www.botaneco.ca.
About SemBioSys (TSX:SBS)
Calgary, Alberta-based SemBioSys Genetics Inc. is a biotechnology
company developing protein-based pharmaceuticals for metabolic and
cardiovascular diseases. The Company's lead pharmaceutical candidates,
produced in the plant host safflower, are recombinant human insulin, to
serve the rapidly expanding global diabetes market and Apo AI, a next
|SOURCE SemBioSys Genetics Inc.|
Copyright©2008 PR Newswire.
All rights reserved